Loading
Latest filing published 23 Sept 2025 for Ascelia Pharma AB, €4,840. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter Benson (board member) discloses dealings in Ascelia Pharma AB to Finansinspektionen. Over a trading history stretching from 15 April 2025 to 23 September 2025, the count stands at 3 filings.
On the market, this insider has only ever bought: 1 purchase, €4,840 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 23 September 2025: an open-market purchase of €4,840, in Ascelia Pharma AB. Typically, a trade is published a median of 2 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations